Targeting Treg signaling for the treatment of autoimmune diseases

Curr Opin Immunol. 2015 Dec:37:11-20. doi: 10.1016/j.coi.2015.09.002. Epub 2015 Sep 29.

Abstract

Regulatory T (Treg) cells are crucial players in the prevention of autoimmunity. Treg lineage commitment and functional stability are influenced by selected extracellular signals from the local environment, shaped by distinctive intracellular signaling network, and secured by their unique epigenetic profile. Recent advances in our understanding of the complex processes of Treg lineage differentiation, maintenance, and function has paved the way for developing strategies to manipulate these important cells for therapeutic benefit in many diseases. In this review, we will summarize recent advances in our understanding of Treg biology as well as Treg-targeted therapies in the context of autoimmune disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / therapy*
  • Cell Differentiation
  • Cellular Microenvironment
  • Epigenesis, Genetic
  • Humans
  • Immunotherapy*
  • Molecular Targeted Therapy
  • Signal Transduction / drug effects
  • T-Lymphocytes, Regulatory / drug effects
  • T-Lymphocytes, Regulatory / immunology*